August 7, 2026

CorMedix Inc. (CRMD) Investor Outlook: Exploring a 99.73% Potential Upside in the Biotech Sector

Investors seeking high-growth opportunities in the biotechnology sector might want to pay close attention to CorMedix Inc. (NASDAQ: CRMD). With a market capitalization of $589.17 million and a focus on..

Stoke Therapeutics, Inc. (STOK) Investor Outlook: A Promising 43.5% Upside in Biotech’s Genetic Revolution

Stoke Therapeutics, Inc. (NASDAQ: STOK), a pioneering force in the biotechnology sector, is making waves with its cutting-edge approach to treating severe genetic diseases. Specializing in the healthcare industry, Stoke..

Bicycle Therapeutics plc (BCYC)

⚠️ No article content returned.

..

Nurix Therapeutics, Inc. (NRIX): A Biotech Stock with 32% Upside Potential and Strong Buy Ratings

Nurix Therapeutics, Inc. (NASDAQ: NRIX) stands out in the biotechnology sector, displaying both a promising pipeline and significant investor interest. With its current market capitalization at $2.62 billion, this clinical-stage..

Cogent Biosciences (COGT) Stock Analysis: High Potential with 29.78% Upside and Strong Buy Ratings

Cogent Biosciences, Inc. (NASDAQ: COGT) stands at the forefront of innovation in the biotechnology sector, with its precision therapies targeting genetically defined diseases. This clinical-stage company, headquartered in Waltham, Massachusetts,..

Simulations Plus, Inc. (SLP) Stock Analysis: Evaluating the Healthcare Software Specialist with 7.5% Revenue Growth

Simulations Plus, Inc. (NASDAQ: SLP) stands out in the healthcare sector as a niche player specializing in drug discovery and development software. With a market capitalization of $370.92 million, the..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a 59% Potential Upside in the Biotech Sector

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company headquartered in San Diego, California, is garnering significant attention in the healthcare sector with its focus on developing novel immunology therapeutics. The..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unpacking a 140% Potential Upside for Investors

Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector with a compelling story for investors. Despite recent challenges reflected in its financial performance, Vir’s..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Unveiling an 82.76% Potential Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents an intriguing opportunity for investors navigating the healthcare sector, especially within the niche of specialty and generic drug manufacturing. With a market capitalization of..

SI-BONE, Inc. (SIBN) Stock Analysis: Navigating a 37.82% Potential Upside in the Medical Device Sector

SI-BONE, Inc. (NASDAQ: SIBN), a pioneering entity in the medical device industry, presents an intriguing opportunity for investors looking to capitalize on the healthcare sector’s robust growth. With a market..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 297% Upside Potential Awaits Investor Attention

Niagen Bioscience, Inc. (NASDAQ: NAGE), a prominent player in the biotechnology sector, offers a compelling opportunity for investors seeking high-growth potential in the healthcare industry. Based in Los Angeles, California,..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Uncovering a 21% Upside Potential

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector. With a market capitalization of $896.82 million, Arbutus is focused on developing novel therapeutics..

Pharvaris N.V. (PHVS) Stock Analysis: Unpacking a 40% Potential Upside in the Biotech Sector

Pharvaris N.V. (PHVS) stands out in the biotechnology arena for its focus on developing innovative solutions for rare diseases. Based in Zug, Switzerland, this late-stage biopharmaceutical company is making notable..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Challenges with Biotech Innovation

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a pivotal player in the biotechnology industry, contributing significantly to the development of drug therapies, vaccines, and diagnostics. Despite its current challenges,..

CeriBell, Inc. (CBLL) Stock Report: Exploring a 47% Potential Upside in the Medical Device Sector

Investors are turning their attention to CeriBell, Inc. (NASDAQ: CBLL), a promising player in the healthcare sector, specializing in innovative medical devices. With a market capitalization of $692.45 million, CeriBell..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A Lucrative 53% Upside Potential for Investors

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has captured the attention of investors with its promising pipeline and substantial upside potential. As a player in the healthcare sector, specifically within the..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a 44.93% Potential Upside in Biotech Innovation

Iovance Biotherapeutics, Inc. (IOVA) stands out in the healthcare sector as a pivotal player in the biotechnology industry, with a market capitalization of $2.77 billion. Headquartered in San Carlos, California,..

Immatics N.V. (IMTX) Stock Analysis: Unveiling an 89.67% Potential Upside for Investors

For investors seeking exposure to the transformative potential of biotechnology, Immatics N.V. (NASDAQ: IMTX) presents itself as a compelling opportunity. Specializing in the healthcare sector, this Germany-based biopharmaceutical company is..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Gem with 88.90% Potential Upside

Savara Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is currently making waves in the healthcare sector with its focus on rare respiratory diseases. Known for its lead product candidate, molgramostim,..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Revenue Surge and Strategic Positioning

AMN Healthcare Services Inc (NYSE: AMN), a leader in providing technology-enabled healthcare workforce solutions and staffing services, stands as a pivotal player in the healthcare sector. With its current market..

Search

Funds

August 7, 2026

Search

Funds

August 7, 2026

FTSE 100

Funds